FMO3 and Glucose intolerance: Together, these data suggest that the genetic deficiency of Fmo3 does not significantly alter metabolic hormone levels, but when exposed to TCDD, male Fmo3−/− mice exhibit marked glucose intolerance compared to TCDD-treated Fmo3+/+ controls (Figure 2).